Influenza A/New Caledonia/20/99 (H1N1)

Cat.# 8IN73-3

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers

Price:
-- / 0.1 mg
* All prices excluding VAT
Request an offer
Infectious diseases
  • Cat.#

    8IN73-3

  • Source:

    Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/New Caledonia/20/99 IVR 116.

  • Purification:

    Ultracentrifugation with 10 - 40 % sucrose gradient.

  • Presentation:

    STE, 0.09 % sodium azide (NaN) and 0.005 % thimerosal.

  • Inactivation:

    Thimerosal and beta propiolactone treatment

    This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.

  • Analysis:

    Purity > 90 %

  • Immunological activity:

    Tested with anti-influenza A monoclonal antibodies (Cat. # 3IN5) in ELISA.

  • Application:

    Serological studies of influenza A virus, immunogen for antibody production.

  • Storage:

    -20 °C (-15 … -30 °C allowed)

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

    Product contains thimerosal and sodium azide as a preservative. Although the amounts are very small appropriate care must be taken when handling this product.

  • Additional product information:
  • References:

    Search references from PubMed

×

Bulk Price Quotation

Influenza A/New Caledonia/20/99 (H1N1) (MAb: )

Information

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!